{"id":840,"date":"2017-09-26T19:27:56","date_gmt":"2017-09-26T19:27:56","guid":{"rendered":"https:\/\/www.estragyn.ca\/fr\/?page_id=840"},"modified":"2024-10-10T12:21:58","modified_gmt":"2024-10-10T12:21:58","slug":"references","status":"publish","type":"page","link":"https:\/\/www.estragyn.ca\/fr\/references\/","title":{"rendered":"R\u00e9f\u00e9rences"},"content":{"rendered":"
\n
\n

R\u00e9f\u00e9rences<\/h3>\n
    \n
  1. Monographie de produit Estragyn cr\u00e8me vaginale. Pharmaceutique Searchlight Inc. 17 ao\u00fbt 2016.<\/li>\n
  2. D. W. Sturdee et N. Panay, au nom du groupe de r\u00e9daction de l\u2019Internationale Menopause Society. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric<\/em> 2010;(13):509-522.<\/li>\n
  3. Frank SM et al.<\/em> Vaginal Health: Insights, Views & Attitudes (VIVA) survey \u2013 Cohorte canadienne, Menopause International<\/em>, mars 2013;(19):20\u201327.<\/li>\n
  4. Marque officielle enregistr\u00e9e de la R\u00e9gie de l’assurance maladie du Qu\u00e9bec; Liste des m\u00e9dicaments, derni\u00e8re mise \u00e0 jour le 4 juillet 2024. Disponible \u00e0 l’adresse https:\/\/www.ramq.gouv.qc.ca\/sites\/default\/files\/documents\/non_indexes\/liste_med_2024-07-04_fr.pdf<\/a>. Consult\u00e9 le 23 ao\u00fbt 2024.<\/li>\n
  5. Sant\u00e9 Canada. Renseignements sur le produit Estragyn cr\u00e8me vaginale.<\/li>\n
  6. Donn\u00e9es au dossier. Pharmaceutique Searchlight. 2024<\/li>\n
  7. La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada. SOGC Clinical Practice Guideline, No 311, septembre 2014.<\/li>\n
  8. Liste des services de sant\u00e9 non assures 2020. Disponible \u00e0 l\u2019adresse https:\/\/www.sac-isc.gc.ca\/DAM\/DAM-ISC-SAC\/DAM-HLTH\/STAGING\/texte-text\/nihb_benefits-services_drugs_dbl-index_1573154657223_fra.pdf<\/a>. Consult\u00e9e le 26 juillet 2021.<\/li>\n
  9. Formulary Nova Scotia, juillet 2021. Disponible \u00e0 l\u2019adresse https:\/\/novascotia.ca\/dhw\/pharmacare\/documents\/formulary.pdf<\/a>. Consult\u00e9 le 26 juillet 2021.<\/li>\n
  10. Formulaire des r\u00e9gimes de m\u00e9dicaments du Nouveau-Brunswick, ao\u00fbt 2024. Disponible \u00e0 l\u2019adresse https:\/\/www2.gnb.ca\/content\/dam\/gnb\/Departments\/h-s\/pdf\/fr\/RegimeMedicamentsN-B\/RegimeMedicamentsN-B.pdf<\/a>. Consult\u00e9 le 23 ao\u00fbt 2024.<\/li>\n
  11. Manitoba Drug Benefits, 24 f\u00e9vrier 2022. Disponible \u00e0 l\u2019adresse https:\/\/www.gov.mb.ca\/health\/mdbif\/docs\/bulletins\/bulletin116.pdf<\/a>. Consult\u00e9 le 23 ao\u00fbt 2024.<\/li>\n
  12. Saskatchewan Formulary Bulletin, 1 f\u00e9vrier 2022. Disponible \u00e0 l\u2019adresse https:\/\/formulary.drugplan.ehealthsask.ca\/Bulletins\/Bulletin-0210-Feb-2022.pdf<\/a>. Consult\u00e9 le 23 ao\u00fbt 2024.<\/li>\n
  13. The North American Menopause Society. D\u00e9claration de principes. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause<\/em>, 2017. Disponible \u00e0 l\u2019adresse\u00a0https:\/\/www.menopause.org\/docs\/default-source\/professional\/nams-2022-hormone-therapy-position-statement.pdf<\/a>. Consult\u00e9 le 12 septembre, 2023.<\/li>\n<\/ol>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

    R\u00e9f\u00e9rences Monographie de produit Estragyn cr\u00e8me vaginale. Pharmaceutique Searchlight Inc. 17 ao\u00fbt 2016. D. W. Sturdee et N. Panay, au nom du groupe de r\u00e9daction de l\u2019Internationale Menopause Society. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 2010;(13):509-522. Frank SM et al. Vaginal Health: Insights, Views & Attitudes (VIVA) survey \u2013 Cohorte canadienne, Menopause […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-840","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.estragyn.ca\/fr\/wp-json\/wp\/v2\/pages\/840","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.estragyn.ca\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.estragyn.ca\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.estragyn.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.estragyn.ca\/fr\/wp-json\/wp\/v2\/comments?post=840"}],"version-history":[{"count":18,"href":"https:\/\/www.estragyn.ca\/fr\/wp-json\/wp\/v2\/pages\/840\/revisions"}],"predecessor-version":[{"id":1092,"href":"https:\/\/www.estragyn.ca\/fr\/wp-json\/wp\/v2\/pages\/840\/revisions\/1092"}],"wp:attachment":[{"href":"https:\/\/www.estragyn.ca\/fr\/wp-json\/wp\/v2\/media?parent=840"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}